What is 3D Bioprinting? News Podcast Gallery Submit a Story 3D bioprinting builds on decades of technological advances of biological science, printing, and manufacturing to produce three-dimensional biological structures from raw biomaterials . 3D bioprinting is a type of additive manufacturing that uses biological materials (or bioinks ) to produce structures capable of sustaining life. Additive manufacturing is a process that creates something from nothing. Think of a wooden baseball bat, traditional manufacturing (subtractive manufacturing) starts with a block of wood then chips and whittles away until a finished baseball bat remains. Additive manufacturing does the opposite, starting with a raw material, systematically adding it layer-by-layer until a structure remains. 3D bioprinting typically utilizes the additive process of layer-by-layer deposit of material. What is 3D Bioprinting? Scientists create 3D computer models using medical and microscopic imaging : MRI, CT, confocal microscope, etc. These 3D models could be used to print structures from scratch and/or to add to existing structures. Further 3D scans and analysis can also be used to monitor print progress as well as cell/structure progress post-print. A key component of human applications for bioprinted materials and structures will be the ability to vascularize the cells . Vascularization is the process of growing blood vessels to delivery necessary nutrients to cells: actually create living cells . 3D bioprinting can produce many structures and materials for a variety of use and purposes, including: drug testing , research and development , creation of tissue structures and even organs , bone and skin grafts, and more. The applications for such materials is only in its infancy, with a promising future for a variety of research purposes as well as further treatments and curative uses in humans. 3D bioprinters come in a variety of sizes for use in a myriad of applications from teaching , benchtop , clean room , to sterile environments . The most advanced 3D bioprinters use robotics and artificial intelligence to mimic how a human would interact with the biology. These advanced bioprinters have the ability to "change hands " allowing for full lab automation to provide researchers the flexibility to do more. ​ JOIN THE COMMUNITY TO STAY UP TO DATE ON THE LATEST 3D BIOPRINTING DEVELOPMENTS

Store All Products Bioprinters Incubators Supplies Software 0 Software Software for BioBot Basic and BioAssemblyBots 200, 400, & 500 Buy Now Learn More Get Quote Learn More Get Started Learn More Request Beta Learn More

GET QUOTE Create Your Own BioApp Advanced Solutions Talk with an Expert Schedule a Demo Do you have a repetitive task that you'd like to eliminate? With BioApps, multi-step processes are done without human interaction. Turn your experiment into an automated workflow by quickly stitching together custom experimental protocols to build assays and tissues. BioApps does the rest telling your BioAssemblyBot what to do, controlling cell analysis, liquid handling, bioprocessing, and equipment. Producing consistent, repeatable experiments. Create your own BioApp integrating the BioAssemblyBot 200 or BioAssemblyBot 400 , BioStorageBot, the Cytiva IN Cell Analyzer, TSIM , and Angiomics Microvessels . The possibilities are endless. Talk with an Expert Schedule a Demo BioApps is compatible with: Cytiva IN Cell Analyzer GetStarted Get started creating your BioApp:

Advanced Solutions Life Sciences (ASLS) and Epson Robots have revolutionized biotechnology with the BioAssemblyBot (BAB), a platform that leverages Epson's advanced robotics for precise Biofabrication, such as 3D printing human tissues and organs. This collaboration highlights ASLS's innovative approach to automating complex biological manufacturing tasks, pushing the boundaries of what's possible in life sciences. For more details on this groundbreaking project, visit the Epson case study

FOR IMMEDIATE RELEASE Advanced Solutions Chief Scientist, Dr. James Hoying, to Present Tutorial on Automated Workflow for Tissue Organoid Modeling in Collaboration with Molecular Devices at SLAS 2023 San Diego, CA, February, 24, 2023 - Advanced Solutions, a leader in bioprinting technology, and Molecular Devices, a leading provider of high-performance bioanalytical measurement solutions, are pleased to announce that they will be co-sponsoring a tutorial on the automated workflow for tissue organoid modeling at the SLAS 2023 Conference in San Diego, CA. The tutorial will be presented by Dr. James Hoying, Chief Scientist at Advanced Solutions, and Dr. Oksana Sirenko, Senior Scientist at Molecular Devices, on Monday, February 27, 2023, from 12:00 PM to 1:00 PM PST in Room 1B of the San Diego Convention Center. Tissue organoids and other 3D biological models have revolutionized biomedical research, particularly in the fields of drug and target discovery. However, deploying these models quickly and effectively requires turnkey workflow solutions that align automation with biology. This tutorial will describe an automated workflow for forming, bioprinting, culturing, transferring, assaying, and analyzing tissue organoid models using the BioAssemblyBot® 400 bioprinter and ImageXpress® Confocal HT.ai High-Content Imaging System. The session will also explore different tissue models, including patient-derived cancer organoids (PDOs), and discuss their use with various automated workflows. “We are excited to partner with Molecular Devices to present this tutorial at SLAS 2023,” said Dr. James Hoying, Chief Scientist at Advanced Solutions. “As tissue organoid modeling becomes increasingly important in biomedical research, it is critical that scientists have access to turnkey workflow solutions that can deploy these models quickly and accurately. This tutorial will provide a valuable overview of the latest automated workflow solutions for tissue organoid modeling, and we look forward to sharing our expertise with the SLAS community.” To attend this tutorial, please register for the SLAS 2023 Conference and visit Room 1B of the San Diego Convention Center on Monday, February 27, 2023, from 12:00 PM to 1:00 PM PST. For more information about the tutorial, please contact Advanced Solutions or Molecular Devices. About Advanced Solutions Advanced Solutions is a leader in 3D biotechnology, providing a range of solutions for tissue engineering, regenerative medicine, and drug discovery. The company’s BioAssemblyBot® platform is a fully automated bioprinting system that enables researchers to create complex solutions for a range of applications. For more information, please visit www.advancedsolutions.com. About Molecular Devices Molecular Devices is a leading provider of high-performance bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company’s solutions enable scientists to explore life at the cellular level and improve human health. For more information, please visit www.advancedsolutions.com/molecular-devices.

The field of life sciences is advancing at a breakneck pace, and innovation is the driving force behind it all. At the forefront of this effort is Advanced Solutions Life Sciences (ASLS), a company dedicated to the discovery, design, and development of integrated software, hardware, and biological solutions. With its focus on integrating engineering and biology, ASLS is pushing the boundaries of what is possible in biomedical and biotechnology. What better platform for ASLS to showcase its cutting-edge technology than the Society for Laboratory Automation and Screening (SLAS) 2023 conference. The conference is a gathering of the brightest minds in the field of laboratory automation, bringing together academic, industry, and government researchers, as well as developers and providers of technology and tools. SLAS provides a unique opportunity for ASLS to demonstrate its patented BioAssemblyBot 3D Biofabrication Technology Platforms, TSIM Software, and VIPM. At the heart of ASLS's technology is the BioAssemblyBot, a highly sophisticated and agile robotic platform designed to revolutionize the world of biofabrication. With its ability to assemble biological structures with speed, precision, and cost-effectiveness, the BioAssemblyBot is set to shape the future of personalized medicine, cancer research, high-throughput assays, and regenerative therapeutics. ASLS's technology is already being used by some of the world's top global healthcare brands, and its products are UL cGMP certified, ensuring safety and quality. Visitors to the ASLS booth (#604 in the exhibition) at SLAS 2023 will have the chance to see the BioAssemblyBot in action and learn about the company's latest advancements in the field of biofabrication. In addition to showcasing its technology, ASLS will also be represented by Dr. Jay Hoying, the Chief Scientist of Advanced Solutions Life Sciences (ASLS). Dr. Hoying will be presenting on the topic of Automation of Complex Organoid Culture and Assay Workflows. This presentation is a rare opportunity for attendees to gain insights into the innovative work being done by ASLS in the field of biofabrication. SLAS 2023 San Diego, CA, USA February 25 - March 1, 2023 Advanced Solutions Life Sciences Exhibition Exhibition Hall (Booth #604) Sunday, February 26 from 4 PM to 7 PM Monday, February 27 from 10 AM to 6 PM Tuesday, February 28 from 10 AM to 6 PM Dr. Jay Hoying Presentation Poster Theater (#555 in Exhibition) Tuesday, February 28 from 1:40 PM - 1:50 PM

In this course, you will learn: -A brief overview about BAB -Vending Portal, Sessions, and Scheduling Time -BAB Hands -Safety -Inside BAB -Using TSIM with BAB -BAB & the user interface -Cleaning